MEDICAL PROGRESS - HODGKINS-DISEASE

被引：227

作者：

URBA, WJ ^{[1
]}

LONGO, DL ^{[1
]}

机构：

[1] NCI, FREDERICK CANC RES & DEV CTR, BIOL RESPONSE MODIFIERS PROGRAM, FREDERICK, MD 21701 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1992年 / 326卷 / 10期

关键词：

D O I：

10.1056/NEJM199203053261006

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：678 / 687

页数：10

共 175 条

[61] HODGKIN DISEASE - CLINICAL UTILITY OF CT IN INITIAL STAGING AND TREATMENT [J].

HOPPER, KD ;

DIEHL, LF ;

LESAR, M ;

BARNES, M ;

GRANGER, E ;

BAUMANN, J .

RADIOLOGY, 1988, 169 (01) :17-22

[62] VINBLASTINE, BLEOMYCIN, AND METHOTREXATE - AN EFFECTIVE ADJUVANT IN FAVORABLE HODGKINS-DISEASE [J].

HORNING, SJ ;

HOPPE, RT ;

HANCOCK, SL ;

ROSENBERG, SA .

JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (12) :1822-1831

[63]

HSU SM, 1990, BLOOD, V75, P1742

[64] PROGNOSTIC FACTORS FOR RESPONSE AND SURVIVAL AFTER HIGH-DOSE CYCLOPHOSPHAMIDE, CARMUSTINE, AND ETOPOSIDE WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR RELAPSED HODGKINS-DISEASE [J].

JAGANNATH, S ;

ARMITAGE, JO ;

DICKE, KA ;

TUCKER, SL ;

VELASQUEZ, WS ;

SMITH, K ;

VAUGHAN, WP ;

KESSINGER, A ;

HORWITZ, LJ ;

HAGEMEISTER, FB ;

MCLAUGHLIN, P ;

CABANILLAS, F ;

SPITZER, G .

JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (02) :179-185

[65] THE SIGNIFICANCE OF THE RESIDUAL MEDIASTINAL MASS IN TREATED HODGKINS-DISEASE [J].

JOCHELSON, M ;

MAUCH, P ;

BALIKIAN, J ;

ROSENTHAL, D ;

CANELLOS, G .

JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (05) :637-640

[66] HIGH-DOSE CYTOTOXIC THERAPY AND BONE-MARROW TRANSPLANTATION FOR RELAPSED HODGKINS-DISEASE [J].

JONES, RJ ;

PIANTADOSI, S ;

MANN, RB ;

AMBINDER, RF ;

SEIFTER, EJ ;

VRIESENDORP, HM ;

ABELOFF, MD ;

BURNS, WH ;

MAY, WS ;

ROWLEY, SD ;

VOGELSANG, GB ;

WAGNER, JE ;

WILEY, JM ;

WINGARD, JR ;

YEAGER, AM ;

SARAL, R ;

SANTOS, GW .

JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (03) :527-537

[67] LEUKEMIA FOLLOWING HODGKINS-DISEASE [J].

KALDOR, JM ;

DAY, NE ;

CLARKE, EA ;

VANLEEUWEN, FE ;

HENRYAMAR, M ;

FIORENTINO, MV ;

BELL, J ;

PEDERSEN, D ;

BAND, P ;

ASSOULINE, D ;

KOCH, M ;

CHOI, W ;

PRIOR, P ;

BLAIR, V ;

LANGMARK, F ;

KIRN, VP ;

NEAL, F ;

PETERS, D ;

PFEIFFER, R ;

KARJALAINEN, S ;

CUZICK, J ;

SUTCLIFFE, SB ;

SOMERS, R ;

PELLAECOSSET, B ;

PAPPAGALLO, GL ;

FRASER, P ;

STORM, H ;

STOVALL, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (01) :7-13

[68] THE PATHOLOGICAL AND CLINICAL HETEROGENEITY OF LYMPHOCYTE-DEPLETED HODGKINS-DISEASE [J].

KANT, JA ;

HUBBARD, SM ;

LONGO, DL ;

SIMON, RM ;

DEVITA, VT ;

JAFFE, ES .

JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (03) :284-294

[69]

KESSINGER A, 1989, BLOOD, V74, P1260

[70] LONG-TERM FOLLOW-UP OF TESTICULAR FUNCTION FOLLOWING RADIATION-THERAPY FOR EARLY-STAGE HODGKINS-DISEASE [J].

KINSELLA, TJ ;

TRIVETTE, G ;

ROWLAND, J ;

SORACE, R ;

MILLER, R ;

FRAASS, B ;

STEINBERG, SM ;

GLATSTEIN, E ;

SHERINS, RJ .

JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (06) :718-724

← 2 3 4 5 6 7 8 9 10 11 →